Inventor · disambiguated record
Erik D'Hondt
Also filed as: D'HONDT ERIK · D'Hondt Erik Jozef · DHONDT ERIK
12 granted patents·8 pending applications·47 citations·filing 2000–2022
87Inventor score
Top patents by PatentIndex Score
20 records- 0190US11198716B2Recombinant proteins and their therapeutic usesIN3BIO LTD·Filed 2017·Granted Dec 14, 2021·6 cites·15 claims
- 0287US12030920B2Recombinant proteins and their therapeutic usesIN3BIO LTD·Filed 2021·Granted Jul 9, 2024·1 cites·12 claims
- 0382US7238349B1CompositionSAECHSISCHES SERUMWERK·Filed 2000·Granted Jul 3, 2007·30 cites·17 claims
- 0480US9902760B2Recombinant proteins and their therapeutic usesBIOVEN 3 LTD·Filed 2012·Granted Feb 27, 2018·7 cites·8 claims
- 0579US11419923B2Self-assembling synthetic proteinsIN3BIO LTD·Filed 2020·Granted Aug 23, 2022·1 cites·9 claims
- 0676US12134662B2Synthetic proteins and therapeutic uses thereofIN3BIO LTD·Filed 2018·Granted Nov 5, 2024·1 cites·19 claims
- 0773US12433939B2Self-assembling synthetic proteins comprising cholera toxin beta subunitIN3BIO LTD·Filed 2022·Granted Oct 7, 2025·0 cites·9 claims
- 0870US10736948B2Epidermal growth factor fusion proteins with mutant cholera toxin B subunitsCHARLTON KEITH ALAN·Filed 2015·Granted Aug 11, 2020·1 cites·9 claims
- 0959US12258389B2Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitorsIN3BIO LTD·Filed 2021·Granted Mar 25, 2025·0 cites·7 claims
- 1057US2007141078A1Influenza vaccineD HONDT ERIK·Filed 2006·Application pending·0 cites
- 1149US2004213806A1Salmonella typhi vaccine compositionsSMITHKLINE BEECHAM BIOLOG·Filed 2004·Application pending·0 cites
- 1249US2005112144A1Hepatitis A vaccinesSMITHKLINE BEECHAM BIOLOG·Filed 2004·Application pending·0 cites
- 1348US2016207972A1Recombinant proteins and their therapeutic usesBIOVEN 3 LTD·Filed 2016·Application pending·0 cites
- 1448US2022305105A1Stabilized chimeric synthetic proteins and therapeutic uses thereofIN3BIO LTD·Filed 2020·Application pending·0 cites
- 1545US12257245B2Methods and compositions for inhibition of EGF/EGFR pathway in combination with anaplastic lymphoma kinase inhibitorsIN3BIO LTD·Filed 2019·Granted Mar 25, 2025·0 cites·3 claims
- 1645US10398771B2Process for producing influenza vaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Sep 3, 2019·0 cites·17 claims
- 1744US2004151735A1HCV compositionsINNOGENETICS·Filed 2003·Application pending·0 cites
- 1844US2022378891A1Methods and compositions for use of growth factor antibodies in combination with non-tyrosine targeting kinase inhibitorsIN3BIO LTD·Filed 2020·Application pending·0 cites
- 1942US2019358320A1Methods and compositions for inhibition of egf/egfr pathway in combination with tyrosine kinase inhibitorsIN3BIO LTD·Filed 2019·Application pending·0 cites
- 2035US9636394B2Process for producing influenza vaccineD'Hondt Erik Jozef·Filed 2010·Granted May 2, 2017·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Erik D'Hondt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →